An FDA advisory committee voted on Thursday to add peptides including BPC-157 and Semax to the list of substances permitted for pharmacy compounding. The vote, which opposed some FDA scientists' positions, would make these peptides more accessible to physicians.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
FDA panel votes to place popular peptide BPC-157 on compounding list Reuters
An FDA advisory committee voted on Thursday to add the popular peptide BPC-157 to a drug compounding list.
The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits. The FDA's Pharmacy Compounding Advisory Committee (PCAC) heard public comments and saw presentation by agency staffers co
this outlet adds: while, opponents, argued, wasn, enough, data, prove, safety
If the FDA allows compounding pharmacies to make #peptides into specialized medicines for physicians to prescribe, it would make peptides more accessible... #bpc157 #woundhealing www.medestheticsmag.com/home/article... FDA Pharmacy Committee votes to expand BPC-157 access through compounding pharmacies. Learn about the peptide's potential benefits for muscle and tissue healing.
FDA advisory panel recommends peptide Semax be added to pharmacy compounding list Reuters
www.reuters.com/legal/litiga... FDA advisory panel recommends peptide called Semax be added to pharmacy compounding list. The panel has backed five other peptides. FDA is not bound by the panel's recommendations. A panel of advisers to the U.S. Food and Drug Administration on Friday voted to place a popular peptide called Semax on a list that would allow broader pharmacy compounding.
An advisory committee for the Food and Drug Administration has narrowly voted to add six peptides to a drug compounding list.
www.yahoo.com/news/science... The Pharmacy Compounding Advisory Committee voted 8-6 to recommend BPC-157, KPV, TB-500, and MOTS-c for compounding pharmacy access